--- title: "3SBIO drops 5% as US plans curbs on China biotech investment" type: "News" locale: "en" url: "https://longbridge.com/en/news/303156992.md" description: "3SBIO fell 5.25% to HK$13.18 as a U.S. proposal to restrict biotech investment in China weighed on the sector." datetime: "2026-10-27T02:54:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/303156992.md) - [en](https://longbridge.com/en/news/303156992.md) - [zh-HK](https://longbridge.com/zh-HK/news/303156992.md) generator: "portal-rs" --- # 3SBIO drops 5% as US plans curbs on China biotech investment 3SBIO (1530.HK) fell more than **5%** in Hong Kong trading to **HK$13.18**. The U.S. Department of the Treasury released a draft of the Comprehensive Outbound Investment National Security Act, proposing restrictions on biotechnology investment in China. The proposal triggered a market reaction, weighing on shares of innovative drugmakers. Although the policy has not yet been implemented and total outbound licensing deals for Chinese innovative drugs reached **$130 billion** in the first three quarters, industry participants are monitoring whether the measures could disrupt overseas expansion trends or affect equity investments and NewCo structures. Based on public media reports. AI-generated; not investment advice. ### Related Stocks - [01530.HK](https://longbridge.com/en/quote/01530.HK.md) ## Related News & Research - [Citi: 2026 NRDL Negotiation Results Released; Drugmakers Say Price Cuts Mild and Manageable](https://longbridge.com/en/news/306083646.md) - [SanRex proposes to acquire Frontage Holdings for HKD 2.370 per share](https://longbridge.com/en/news/304839252.md) - [Indonesia's OJK fines and sanctions firms for stock manipulation, disclosure failures](https://longbridge.com/en/news/306356743.md) - [Public Power Corporation S.A. Just Missed Revenue By 7.1%: Here's What Analysts Think Will Happen Next](https://longbridge.com/en/news/306350012.md) - [Concerns Surrounding Srinibas Pradhan Constructions' (NSE:SPCON) Performance](https://longbridge.com/en/news/306347727.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**